15/11/2020

The US Food and Drug Administration (FDA) has authorized IQOS for sale in the United States

It is the first electronic tobacco heating device to be approved by the FDA for sale in the United States.

"The goal of all of us at Philip Morris is to completely replace cigarettes with smokeless products that are a combination of sophisticated technology and advanced science," said Andre Kalancopoulos, the company's CEO, emphasizing that the FDA's decision is a historic milestone.

Philip Morris has submitted comprehensive scientific research to the FDA to provide support for its two applications - the first (PMTA), which is approved for the commercialization of IQOS in the US market, and the second, which is still under consideration. to classify this product as a “modified risk tobacco product” (MRTP).

Najnovije vesti

The We Edition IQOS 3 DUO
Pročitaj više
Izabrali smo 10 najboljih na IQOS kastingu
Pročitaj više
ZAGREJANI ZA NAŠ GRAD
Pročitaj više
We are one step closer to finding "The Face of World IQOS community"
Pročitaj više
More to discover with myIQOS​
Care you can count on.

Privileges to inspire you.​
Care you can count on
Access our personal coaches for support on how to get the best use from your IQOS. ​
Loyalty rewards
Earn points for member offers, device upgrades and exciting benefits.
Peace of mind
Accidental damage cover, rapid replacement and international assistance.
This product is not risk-free and delivers nicotine, which is addictive. For adult use only.​